ZA94925B - Silylated acetylcholinesterase inhibitors - Google Patents

Silylated acetylcholinesterase inhibitors

Info

Publication number
ZA94925B
ZA94925B ZA94925A ZA94925A ZA94925B ZA 94925 B ZA94925 B ZA 94925B ZA 94925 A ZA94925 A ZA 94925A ZA 94925 A ZA94925 A ZA 94925A ZA 94925 B ZA94925 B ZA 94925B
Authority
ZA
South Africa
Prior art keywords
silylated
acetylcholinesterase inhibitors
compounds
methods
acetylcholinesterase
Prior art date
Application number
ZA94925A
Other languages
English (en)
Inventor
Jean-Noel Collard
Jean-Marie Hornsperger
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA94925B publication Critical patent/ZA94925B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA94925A 1993-02-16 1994-02-10 Silylated acetylcholinesterase inhibitors ZA94925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93400385A EP0611769A1 (en) 1993-02-16 1993-02-16 Silylated acetylcholinesterase inhibitors

Publications (1)

Publication Number Publication Date
ZA94925B true ZA94925B (en) 1994-08-25

Family

ID=8214682

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA94925A ZA94925B (en) 1993-02-16 1994-02-10 Silylated acetylcholinesterase inhibitors

Country Status (19)

Country Link
EP (2) EP0611769A1 (no)
JP (1) JP3516955B2 (no)
KR (1) KR100336547B1 (no)
CN (1) CN1043575C (no)
AT (1) ATE152725T1 (no)
AU (1) AU672885B2 (no)
CA (1) CA2154870C (no)
DE (1) DE69403068T2 (no)
DK (1) DK0684951T3 (no)
ES (1) ES2104358T3 (no)
FI (1) FI111461B (no)
GR (1) GR3024151T3 (no)
HU (1) HUT72736A (no)
IL (1) IL108623A0 (no)
MX (1) MX9401175A (no)
NO (1) NO305517B1 (no)
NZ (1) NZ262247A (no)
WO (1) WO1994019356A1 (no)
ZA (1) ZA94925B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0627400A1 (en) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatic acetylcholinesterase inhibitors
CN100431539C (zh) * 2004-01-12 2008-11-12 和泓生物技术(上海)有限公司 乙酰胆碱酯酶抑制剂在制备治疗帕金森病药物中的应用
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
US8486940B2 (en) 2009-09-11 2013-07-16 Probiodrug Ag Inhibitors
CN109662964A (zh) 2010-02-09 2019-04-23 约翰斯.霍普金斯大学 用于改善认知功能的方法和组合物
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
CN102791704B (zh) 2010-03-10 2015-11-25 前体生物药物股份公司 谷氨酰胺酰环化酶(qc, ec 2.3.2.5)的杂环抑制剂
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
AU2014228512A1 (en) 2013-03-15 2015-10-01 Agenebio, Inc. Methods and compositions for improving cognitive function
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2986598C (en) 2015-05-22 2023-09-26 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
CN112047973B (zh) * 2019-06-06 2022-11-18 上海科技大学 一种大麻素类化合物,其制备方法、组合物和用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403713A1 (en) * 1989-06-22 1990-12-27 Merrell Dow Pharmaceuticals Inc. Novel acetylcholinesterase inhibitors

Also Published As

Publication number Publication date
FI953851A0 (fi) 1995-08-15
FI111461B (fi) 2003-07-31
WO1994019356A1 (en) 1994-09-01
NZ262247A (en) 1996-01-26
IL108623A0 (en) 1994-05-30
MX9401175A (es) 1994-08-31
DK0684951T3 (da) 1997-05-26
EP0684951B1 (en) 1997-05-07
AU672885B2 (en) 1996-10-17
CA2154870A1 (en) 1994-09-01
CA2154870C (en) 1998-10-27
GR3024151T3 (en) 1997-10-31
ES2104358T3 (es) 1997-10-01
EP0684951A1 (en) 1995-12-06
NO305517B1 (no) 1999-06-14
HUT72736A (en) 1996-05-28
CN1117733A (zh) 1996-02-28
JP3516955B2 (ja) 2004-04-05
CN1043575C (zh) 1999-06-09
FI953851A (fi) 1995-08-15
DE69403068D1 (en) 1997-06-12
JPH08507059A (ja) 1996-07-30
EP0611769A1 (en) 1994-08-24
AU6164194A (en) 1994-09-14
ATE152725T1 (de) 1997-05-15
DE69403068T2 (de) 1997-12-11
NO953201D0 (no) 1995-08-15
KR100336547B1 (ko) 2002-11-02
KR960701068A (ko) 1996-02-24
NO953201L (no) 1995-08-15

Similar Documents

Publication Publication Date Title
HU9503452D0 (en) Aromatic acetylcholinesterase inhibitors
GR3024151T3 (en) Silylated acetylcholinesterase inhibitors.
HUT71550A (en) Pharmaceutical agents containing quinuclidine, piperidine or azanorbornane derivatives for treatment of emesis
AU2207897A (en) Methods of treating or preventing interstitial cystitis
GR3030269T3 (en) Use of il-10 to prevent or treat insulin-dependent diabetes mellitus.
EP0630383A4 (en) METHODS OF TREATING DIABETES.
HU9301169D0 (en) Method for improving flame-proofness of plastics by means of addition of guanidine-barbiturates and/or guanidine-thiobarbiturates as burning inhibitors, flame-proof plastics containing said compounds as well as these compounds
AU6410394A (en) Method of treating addictive behaviors
ZA912236B (en) Hydroxymethyl-indolizidines and quinolizidines
GB9317943D0 (en) Treatment of laminitis
GB9317989D0 (en) Treatment of laminitis
HU9301187D0 (en) Method for treating tumours being dependent of gar-transformylase
EP0608702A3 (de) Verfahren zum Behandeln von Haselnüssen.
EP0932406A4 (en) METHODS OF TREATING OR PREVENTING INTERSTITIAL CYSTITIS
EP0654997A4 (en) COMPOSITIONS OF SUBSTITUTED AZASPIRANS AND METHOD FOR TREATING PSORIASIS THEREFOR.
GB9314466D0 (en) Methods of treating diamonds
GB9326020D0 (en) Novel method of treatment
GB9308853D0 (en) Novel method of treatment